BMY Bristol Myers Squibb Co

Price (delayed)

$64.44

Market cap

$143.88B

P/E Ratio

N/A

Dividend/share

$1.88

EPS

-$2.75

Enterprise value

$179.18B

Sector: Healthcare
Industry: Drug Manufacturers - General

Bristol Myers Squibb is an American pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, ...

Highlights

Bristol Myers Squibb's gross profit has soared by 51% YoY and by 3.6% from the previous quarter
The company's revenue rose by 38% YoY
Bristol Myers Squibb's equity has decreased by 25% YoY
The quick ratio has decreased by 9% YoY and by 2.3% QoQ

Key stats

What are the main financial stats of BMY
Market
Shares outstanding
2.23B
Market cap
$143.88B
Enterprise value
$179.18B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.84
Price to sales (P/S)
3.37
EV/EBIT
N/A
EV/EBITDA
27.5
EV/Sales
4.19
Earnings
Revenue
$42.81B
EBIT
-$4.06B
EBITDA
$6.52B
Free cash flow
$13.24B
Per share
EPS
-$2.75
Free cash flow per share
$5.91
Book value per share
$16.78
Revenue per share
$19.11
TBVPS
$18.34
Balance sheet
Total assets
$112.44B
Total liabilities
$74.76B
Debt
$46.28B
Equity
$37.61B
Working capital
$9.78B
Liquidity
Debt to equity
1.23
Current ratio
1.56
Quick ratio
1.25
Net debt/EBITDA
5.42
Margins
EBITDA margin
15.2%
Gross margin
74.4%
Net margin
-14.5%
Operating margin
-9.4%
Efficiency
Return on assets
-5.1%
Return on equity
-14.2%
Return on invested capital
-7.2%
Return on capital employed
-4.3%
Return on sales
-9.5%
Dividend
Dividend yield
2.92%
DPS
$1.88
Payout ratio
N/A

BMY stock price

How has the Bristol Myers Squibb stock price performed over time
Intraday
-0.03%
1 week
3.24%
1 month
3.83%
1 year
5.57%
YTD
3.89%
QTD
2.08%

Financial performance

How have Bristol Myers Squibb's revenue and profit performed over time
Revenue
$42.81B
Gross profit
$31.86B
Operating income
-$4.04B
Net income
-$6.22B
Gross margin
74.4%
Net margin
-14.5%
Bristol Myers Squibb's gross profit has soared by 51% YoY and by 3.6% from the previous quarter
The operating margin has increased by 42% since the previous quarter
The operating income rose by 41% since the previous quarter
The company's revenue rose by 38% YoY

Growth

What is Bristol Myers Squibb's growth rate over time

Valuation

What is Bristol Myers Squibb stock price valuation
P/E
N/A
P/B
3.84
P/S
3.37
EV/EBIT
N/A
EV/EBITDA
27.5
EV/Sales
4.19
Bristol Myers Squibb's EPS has increased by 31% QoQ
BMY's P/B is 29% below its 5-year quarterly average of 5.4 but 20% above its last 4 quarters average of 3.2
Bristol Myers Squibb's equity has decreased by 25% YoY
The company's revenue rose by 38% YoY
The price to sales (P/S) is 22% less than the 5-year quarterly average of 4.3 and 3.7% less than the last 4 quarters average of 3.5

Efficiency

How efficient is Bristol Myers Squibb business performance
BMY's return on invested capital is up by 41% since the previous quarter
Bristol Myers Squibb's return on sales has increased by 41% QoQ
Bristol Myers Squibb's ROA has increased by 29% from the previous quarter
The ROE has grown by 26% from the previous quarter

Dividends

What is BMY's dividend history
DPS
$1.88
Dividend yield
2.92%
Payout ratio
N/A
Recent dividends

Financial health

How did Bristol Myers Squibb financials performed over time
BMY's total assets is 50% greater than its total liabilities
BMY's total assets is down by 13% year-on-year and by 5% since the previous quarter
The quick ratio has decreased by 9% YoY and by 2.3% QoQ
BMY's debt is 23% greater than its equity
The company's debt to equity rose by 31% YoY but it fell by 8% QoQ
Bristol Myers Squibb's equity has decreased by 25% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.